NCT06225232 - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Cannabis Use Disorder, ModerateCannabis Use Disorder, Severe

Interventions

DRUG

Psilocybin combined with Psychotherapy

The intervention consists of a 9-week treatment protocol that is based on supportive psychotherapy and Motivational Enhancement Therapy. Overall, the therapy course includes 8 motivational enhancement therapy sessions and two experimental drug sessions.

Trial Locations (1)

L8S 1B8

RECRUITING

MacAnxiety Research Centre, Hamilton